Using stem cells to improve blood flow in patients with severe leg ischemia

Applying induced pluripotent stem cell derived endothelial cells to regenerative therapy in chronic limb threatening ischemia

NIH-funded research Veterans Health Administration · NIH-11091415

This study is testing a new way to help veterans with chronic limb threatening ischemia, a serious condition that can lead to losing a limb, by using special cells to improve blood flow and heal damaged blood vessels.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionVeterans Health Administration NIH-funded
Lab location1 site (Decatur, UNITED STATES)
Project IDNIH-11091415 on NIH RePORTER

What this research studies

This research focuses on developing a new treatment for chronic limb threatening ischemia (CLTI), a severe form of peripheral arterial disease that affects many veterans. The approach involves using induced pluripotent stem cells to create endothelial cells, which are crucial for forming healthy blood vessels. By applying these stem cells, the research aims to enhance blood flow and potentially prevent limb loss in patients who currently have limited treatment options. The study will explore how these stem cells can be effectively used to regenerate damaged blood vessels and improve overall limb health.

Who could benefit from this research

Good fit: Ideal candidates for this research are veterans suffering from chronic limb threatening ischemia who are not suitable for traditional surgical interventions.

Not a fit: Patients with mild peripheral arterial disease or those who are candidates for standard revascularization procedures may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could provide a novel therapy that significantly improves blood flow and reduces the risk of limb loss for patients with severe ischemia.

How similar studies have performed: Previous research has shown promise in using stem cell therapies for vascular diseases, indicating potential for success in this novel application.

Where this research is happening

Decatur, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.